Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk
DAIC
JANUARY 23, 2024
21-23 hsCRP is nonspecific inflammatory marker and an acute phase reactant that predicts the likelihood of a heart attack, stroke, peripheral artery disease and sudden cardiac death among healthy individuals with no history of CV disease, and recurrent events and death in patients with known ASCVD.22 Published 2013 Apr 4.
111 
Let's personalize your content